此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

2026年7月15日 更新者:Novartis Pharmaceuticals

A Prospective Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants With Symptomatic Cryptosporidiosis in Endemic Countries

This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.

研究概览

地位

招聘中

研究类型

观察性的

注册 (估计的)

30

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Novartis Pharmaceuticals

学习地点

    • Nyanza
      • Kisumu、Nyanza、肯尼亚、40100
        • 招聘中
        • Novartis Investigative Site
      • Lusaka、赞比亚、10101
        • 招聘中
        • Novartis Investigative Site
      • Kuala Lumpur、马来西亚、56000
        • 招聘中
        • Novartis Investigative Site
    • Pahang
      • Kuantan、Pahang、马来西亚、25200
        • 招聘中
        • Novartis Investigative Site

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子

接受健康志愿者

不

取样方法

非概率样本

研究人群

Pediatric participants presenting with diarrhea and testing positive for Cryptosporidium by QuikChek™ and microscopy.

描述

Inclusion criteria:

  • Age 6 months to 59 months with diarrhea according to the World Health Organization (WHO) criteria (≥3 loose stools daily for at least 2 days)
  • QuikChek™ and Stool microscopy positive for Cryptosporidium at screening
  • Acute (<7 days), prolonged (lasting 7-13 days), persistent (lasting 14-28 days) or chronic (lasting >28 days) diarrheal illness (≥3 loose stools daily, as defined by WHO) at screening
  • Normal nutritional status, mildly-to-moderately acutely malnourished, or severely acutely malnourished according to WHO definitions (number of participants with severe acute malnutrition will be capped) at screening
  • Parent or primary caregiver is willing to provide informed consent and to comply with study procedures, including provision of whole stool samples at the scheduled time points and willing to be followed up to 21 days

Exclusion criteria:

  • Bloody diarrhea, defined as diarrhea with visible blood in stool as observed by the study team member performing the screening or reported by parent/primary caregiver
  • Other morbidity requiring emergency medical care in an intensive care setting at the time of screening
  • Coincident non-enteric infection including upper or lower respiratory infection at screening
  • Any participant whose parent or primary caregiver is unwilling or unable to cooperate with study procedures, in the investigator's opinion
  • If the parent/primary caregiver managing care of the patient has travel plans out of the study area that would preclude clinic or in-home study visits during the expected study follow-up period

Other protocol-defined inclusion/exclusion criteria may apply.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Cryptosporidiosis Cohort
Pediatric participants with diarrhea due to Cryptosporidium infection.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Number and Percentage of Participants by Chronicity of Diarrhea
大体时间:Baseline

Diarrhea chronicity categories:

  • Acute (<7 days)
  • Prolonged (7-13 days)
  • Persistent (14-28 days)
  • Chronic (>28 days)
Baseline
Number and Percentage of Participants by Severity of Dehydration
大体时间:Baseline, Days 3, 7, 14 and up to Day 21

Dehydration severity categories:

  • None
  • Some
  • Severe
Baseline, Days 3, 7, 14 and up to Day 21
Time to Resolution of Diarrhea and Dehydration
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Baseline, Days 3, 7, 14 and up to Day 21

次要结果测量

结果测量
措施说明
大体时间
Association of Diarrheal Chronicity With Age
大体时间:Baseline
Association of diarrheal chronicity with age will be assessed using the Kruskal-Wallis test.
Baseline
Association of Diarrheal Chronicity With Height
大体时间:Baseline
Association of diarrheal chronicity with height will be assessed using the Kruskal-Wallis test.
Baseline
Association of Diarrheal Chronicity With Weight
大体时间:Baseline
Association of diarrheal chronicity with weight will be assessed using the Kruskal-Wallis test.
Baseline
Association of Diarrheal Chronicity With Sex
大体时间:Baseline
Association of diarrheal chronicity with sex will be assessed using the Fisher exact test.
Baseline
Association of Diarrheal Chronicity With HIV Status
大体时间:Baseline
Association of diarrheal chronicity with HIV status will be assessed using the Fisher exact test.
Baseline
Association of Diarrheal Chronicity With Malnutrition
大体时间:Baseline
Association of diarrheal chronicity with malnutrition will be assessed using the Fisher exact test.
Baseline
Association of Diarrheal Chronicity With Growth Faltering
大体时间:Baseline
Association of diarrheal chronicity with growth faltering will be assessed using the Fisher exact test.
Baseline
Association of Diarrheal Chronicity With Early Weaning
大体时间:Baseline
Association of diarrheal chronicity with early weaning will be assessed using the Fisher exact test.
Baseline
Association of Diarrheal Chronicity With Non-Exclusive Breast Feeding
大体时间:Baseline
Association of diarrheal chronicity with early non-exclusive breast feeding will be assessed using the Fisher exact test.
Baseline
Association of Dehydration Severity With Age
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with age will be assessed using the Kruskal-Wallis test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With Height
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with height will be assessed using the Kruskal-Wallis test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With Weight
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with weight will be assessed using the Kruskal-Wallis test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With Sex
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with sex will be assessed using the Fisher exact test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With HIV Status
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with HIV status will be assessed using the Fisher exact test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With Malnutrition
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with malnutrition will be assessed using the Fisher exact test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With Growth Faltering
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with growth faltering will be assessed using the Fisher exact test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With Early Weaning
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with early weaning will be assessed using the Fisher exact test.
Baseline, Days 3, 7, 14 and up to Day 21
Association of Dehydration Severity With Non-Exclusive Breast Feeding
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Association of dehydration severity with early non-exclusive breast feeding will be assessed using the Fisher exact test.
Baseline, Days 3, 7, 14 and up to Day 21
Number of Oocysts
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Baseline, Days 3, 7, 14 and up to Day 21
Proportion of Participants Shedding Oocysts
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Baseline, Days 3, 7, 14 and up to Day 21
Number of Participants by Parasite Presence Measured by Microscopy and the QuikChek™ Cryptosporidium Rapid Diagnostic Test (RDT)
大体时间:Baseline, Days 3, 7, 14 and up to Day 21
Baseline, Days 3, 7, 14 and up to Day 21
Number of Participants Screened for Each Site by Time of Year
大体时间:Baseline
Number of participants screened (i.e., present with diarrheal illness) for each site by time of year (i.e., per season).
Baseline
Number of Participants Enrolled for Each Site by Time of Year
大体时间:Baseline
Number of participants enrolled (i.e., Cryptosporidium positive) for each site by time of year (i.e., per season).
Baseline

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Novartis Pharmaceuticals、Novartis Pharmaceuticals

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年1月9日

初级完成 (估计的)

2027年5月19日

研究完成 (估计的)

2027年5月19日

研究注册日期

首次提交

2026年6月29日

首先提交符合 QC 标准的

2026年7月15日

首次发布 (实际的)

2026年7月21日

研究记录更新

最后更新发布 (实际的)

2026年7月21日

上次提交的符合 QC 标准的更新

2026年7月15日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅